YORK BIOANALYTICAL SOLUTIONS LIMITED
Get an alert when YORK BIOANALYTICAL SOLUTIONS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-06-08 (in 1mo)
Last made up 2025-05-25
Watchouts
None on the register
Cash
£19M
+60.4% highest in 5 filed years
Net assets
£25M
+16.9% highest in 5 filed years
Employees
82
+1.2% highest in 5 filed years
Profit before tax
£5M
+56.9% highest in 5 filed years
Net assets
7-year trend · vs Industrials median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | £6,453,754 | £7,924,181 | — | £10,820,339 | £11,058,712 | |
| Operating profit | — | — | £1,411,225 | £2,033,939 | — | £2,524,765 | £4,019,113 | |
| Profit before tax | — | — | £1,517,536 | £2,123,439 | £2,528,927 | £3,078,491 | £4,830,781 | |
| Net profit | — | — | £1,214,020 | £1,701,325 | £2,034,499 | £2,385,228 | £3,633,827 | |
| Cash | — | — | £4,944,867 | £7,393,578 | £8,838,264 | £11,620,233 | £18,640,168 | |
| Total assets less current liabilities | — | — | £15,464,207 | £17,310,532 | £19,445,031 | £21,866,259 | £25,478,030 | |
| Net assets | — | — | £15,399,207 | £17,100,532 | £19,135,031 | £21,520,259 | £25,154,086 | |
| Equity | £12,904,536 | £14,185,187 | £15,399,207 | £17,100,532 | £19,135,031 | £21,520,259 | £25,154,086 | |
| Average employees | — | — | 68 | 70 | 75 | 81 | 82 | |
| Wages | — | — | — | — | — | £3,463,568 | £3,746,930 | |
| Directors' remuneration | — | — | £0 | — | £319,437 | £235,439 | £294,703 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+2.2%
£10,820,339 £11,058,712
highest in 4 filed years
-
Cash
+60.4%
£11,620,233 £18,640,168
highest in 5 filed years
-
Net assets
+16.9%
£21,520,259 £25,154,086
highest in 5 filed years
-
Employees
+1.2%
81 82
highest in 5 filed years
-
Operating profit
+59.2%
£2,524,765 £4,019,113
highest in 4 filed years
-
Profit before tax
+56.9%
£3,078,491 £4,830,781
highest in 5 filed years
-
Wages
+8.2%
£3,463,568 £3,746,930
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | 21.9% | 25.7% | — | 23.3% | 36.3% | |
| Net margin | — | — | 18.8% | 21.5% | — | 22.0% | 32.9% | |
| Return on capital employed | — | — | 9.1% | 11.7% | — | 11.5% | 15.8% | |
| Gearing (liabilities / total assets) | — | — | — | — | — | 16.9% | 17.5% | |
| Current ratio | — | — | — | — | — | 5.64x | 5.53x | |
| Interest cover | — | — | 5427.79x | — | — | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- YORK BIOANALYTICAL SOLUTIONS LIMITED 1999-07-12 → present
- FORAY 1218 LIMITED 1999-05-25 → 1999-07-12
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CLIPSTON, Alasdair Stephen | Director | 2024-11-21 | Jan 1982 | British |
| COOK, Allison Mary | Director | 2021-08-13 | May 1963 | British |
| RAUF, Amar | Director | 2026-03-27 | Jan 1983 | British |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CLARKE, Joanna Lindsey | Secretary | 1999-05-25 | 1999-06-25 |
| COOK, Jeremy Nicholas | Secretary | 2008-04-30 | 2011-11-28 |
| SMITH, Ian | Secretary | 1999-10-15 | 2008-04-30 |
| WAKEFIELD, Paul Antony | Secretary | 1999-06-25 | 1999-10-15 |
| ALACON, Dhilum | Director | 2024-08-14 | 2026-04-10 |
| CLARKE, Joanna Lindsey | Director | 1999-05-25 | 1999-06-25 |
| CLAUSEN, Karl Erik | Director | 2016-01-14 | 2017-05-09 |
| COOK, Jeremy Nicholas | Director | 1999-06-30 | 2011-11-28 |
| CROSS, Ray John | Director | 1999-06-25 | 2005-12-02 |
| DARGUE, Robin Lindsay | Director | 2024-09-01 | 2025-12-02 |
| DELBORN, Carl Philip | Director | 2015-04-24 | 2015-12-31 |
| EALES, Darryl Charles | Director | 2001-11-19 | 2003-08-25 |
| FISHER, Jacqueline | Nominee Director | 1999-05-25 | 1999-06-25 |
| JORGENSEN, Lars Linaa | Director | 2016-01-14 | 2023-05-13 |
| LAMERS, Josephus Wilhelmus Johannes | Director | 2016-01-14 | 2021-09-13 |
| LECH, Yvonne Mie Haugaard | Director | 2008-04-30 | 2015-04-30 |
| MANSER, Philipp Daniel | Director | 2017-05-09 | 2018-05-25 |
| NIELSEN, Hans Birk | Director | 2008-04-30 | 2015-11-16 |
| NOCTOR, Terry Anthony Gerard | Director | 1999-06-30 | 2008-04-30 |
| REBHAN, Christian Peter, Doctor | Director | 2023-04-13 | 2023-10-31 |
| SMITH, Ian | Director | 2021-09-13 | 2024-11-29 |
| SMITH, Ian | Director | 1999-06-30 | 2008-04-30 |
| SMITH, John Stephen | Director | 1999-11-19 | 2008-04-30 |
| TENNANT, Karen Ann | Director | 1999-06-30 | 2008-04-30 |
| TUE, Christopher James, Dr | Director | 2015-11-16 | 2016-12-10 |
| UNARAN-SUSAMIS, Betul | Director | 2024-02-15 | 2024-08-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Unilabs Laboratoire D' Analyses Medicales Sa | Corporate entity | Significant influence | 2023-05-12 | Active |
| Mr Karl Erik Clausen | Individual | Significant influence | 2017-09-21 | Ceased 2017-12-19 |
| Mr Philipp Daniel Manser | Individual | significant-influence-or-control-as-firm | 2017-05-09 | Ceased 2017-09-21 |
| Mr Lars Linaa Jorgensen | Individual | significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2023-05-12 |
| Mr Josephus Wilhelmus Johannes Lamers | Individual | significant-influence-or-control-as-firm | 2016-04-06 | Ceased 2021-08-12 |
Filing timeline
Last 20 of 154 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-10 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-23 | AA | accounts | Accounts with accounts type full | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-24 | AA | accounts | Accounts with accounts type full | |
| 2024-11-29 | TM01 | officers | Termination director company with name termination date | |
| 2024-11-21 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-02 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-20 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-29 | AA | accounts | Accounts with accounts type full | |
| 2023-05-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-26 | TM01 | officers | Termination director company with name termination date | |
| 2023-05-26 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-05-26 | PSC07 | persons-with-significant-control | Cessation of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.